Prospective study on the components of metabolic syndrome and the incidence of Parkinson's disease

Parkinsonism and Related Disorders

Volumn 21, Issue 10, 2015, Pages 1148-1155

  Sääksjärvi, Katri ^a   Knekt, Paul ^a   Männistö, Satu ^a   Lyytinen, Jukka ^b   Heliövaara, Markku ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Biological markers; Cohort studies; Metabolic syndrome; Parkinson's disease; Risk factors

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FINLAND; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PARKINSON DISEASE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; AGED; BODY MASS; COMPLICATION; HEALTH SURVEY; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; COHORT STUDIES; FEMALE; FINLAND; HEALTH SURVEYS; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PARKINSON DISEASE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES;

EID: 84942193613     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.07.017     Document Type: Article

References (35)

1. Stampfer M.J. Cardiovascular disease and Alzheimer's disease: common links. J. Intern. Med. 2006, 260:211-223. 10.1111/j.1365-2796.2006.01687.x.
2. Wirdefeldt K., Adami H.O., Cole P., Trichopoulos D., Mandel J. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur. J. Epidemiol. 2011, 26(Suppl. 1):S1-S58. 10.1007/s10654-011-9581-6.
3. Paganini-Hill A. Risk factors for Parkinson's disease: the leisure world cohort study. Neuroepidemiology 2001, 20:118-124.
4. Simon K.C., Chen H., Schwarzschild M., Ascherio A. Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology 2007, 69:1688-1695. 10.1212/01.wnl.0000271883.45010.8a.
5. Qiu C., Hu G., Kivipelto M., Laatikainen T., Antikainen R., Fratiglioni L., et al. Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study. Hypertension 2011, 57:1094-1100. 10.1161/HYPERTENSIONAHA.111.171249.
6. Vikdahl M., Backman L., Johansson I., Forsgren L., Haglin L. Cardiovascular risk factors and the risk of Parkinson's disease. Eur. J. Clin. Nutr. 2014, 10.1038/ejcn.2014.259.
7. de Lau L.M., Koudstaal P.J., Hofman A., Breteler M.M. Serum cholesterol levels and the risk of Parkinson's disease. Am. J. Epidemiol. 2006, 164:998-1002. 10.1093/aje/kwj283.
8. Palacios N., Gao X., McCullough M.L., Jacobs E.J., Patel A.V., Mayo T., et al. Obesity, diabetes, and risk of Parkinson's disease. Mov. Disord. 2011, 26:2253-2259. 10.1002/mds.23855.
9. Abbott R.D., Ross G.W., White L.R., Nelson J.S., Masaki K.H., Tanner C.M., et al. Midlife adiposity and the future risk of Parkinson's disease. Neurology 2002, 59:1051-1057.
10. Chen H., Zhang S.M., Schwarzschild M.A., Hernan M.A., Willett W.C., Ascherio A. Obesity and the risk of Parkinson's disease. Am. J. Epidemiol. 2004, 159:547-555.
11. Hu G., Jousilahti P., Nissinen A., Antikainen R., Kivipelto M., Tuomilehto J. Body mass index and the risk of Parkinson disease. Neurology 2006, 67:1955-1959.
12. Logroscino G., Sesso H.D., Paffenbarger R.S., Lee I.M. Body mass index and risk of Parkinson's disease: a prospective cohort study. Am. J. Epidemiol. 2007, 166:1186-1190.
13. Sääksjärvi K., Knekt P., Männistö S., Lyytinen J., Jääskeläinen T., Kanerva N., et al. Reduced risk of Parkinson's disease associated with lower body mass index and heavy leisure-time physical activity. Eur. J. Epidemiol. 2014, 29:285-292. 10.1007/s10654-014-9887-2.
14. Scigliano G., Musicco M., Soliveri P., Piccolo I., Ronchetti G., Girotti F. Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study. Stroke 2006, 37:1184-1188. 10.1161/01.STR.0000217384.03237.9c.
15. Cereda E., Cassani E., Barichella M., Spadafranca A., Caccialanza R., Bertoli S., et al. Low cardiometabolic risk in Parkinson's disease is independent of nutritional status, body composition and fat distribution. Clin. Nutr. 2012, 31:699-704. 10.1016/j.clnu.2012.02.004.
16. Aromaa A., Heliövaara M., Impivaara O., Knekt P., Maatela J. The Execution of the Mini-Finland Health Survey 1989, Publications of the Social Insurance Institution, ML:88, Helsinki and Turku.
17. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645. 10.1161/CIRCULATIONAHA.109.192644.
18. Terveys ja toimintakyky Suomessa. Terveys 2000 -tutkimuksen perustulokset 2002, Kansanterveyslaitoksen julkaisuja B2/2002, Helsinki. A. Aromaa, S. Koskinen (Eds.).
19. Perk J., De Backer G., Gohlke H., Graham I., Reiner Z., Verschuren M., et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur. Heart J. 2012, 33:1635-1701. 10.1093/eurheartj/ehs092.
20. Weisskopf M.G., Knekt P., O'Reilly E.J., Lyytinen J., Reunanen A., Laden F., et al. Persistent organochlorine pesticides in serum and risk of Parkinson disease. Neurology 2010, 74:1055-1061. 10.1212/WNL.0b013e3181d76a93.
21. Lee J. Covariance adjustment of rates based on the multiple logistic regression model. J. Chronic Dis. 1981, 34:415-426.
22. Graubard B.I., Korn E.L. Predictive margins with survey data. Biometrics 1999, 55:652-659.
23. Knekt P., Kilkkinen A., Rissanen H., Marniemi J., Sääksjärvi K., Heliövaara M. Serum vitamin D and the risk of Parkinson disease. Arch. Neurol. 2010, 67:808-811. 10.1001/archneurol.2010.120.
24. Sääksjärvi K., Knekt P., Rissanen H., Laaksonen M.A., Reunanen A., Männistö S. Prospective study of coffee consumption and risk of Parkinson's disease. Eur. J. Clin. Nutr. 2008, 62:908-915. 10.1038/sj.ejcn.1602788.
25. Hu G., Jousilahti P., Bidel S., Antikainen R., Tuomilehto J. Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 2007, 30:842-847. 10.2337/dc06-2011.
26. Awerbuch G.I., Sandyk R. Autonomic functions in the early stages of Parkinson's disease. Int. J. Neurosci. 1994, 74:9-16.
27. Wakabayashi K., Takahashi H. Neuropathology of autonomic nervous system in Parkinson's disease. Eur. Neurol. 1997, 38(Suppl. 2):2-7.
28. Gaig C., Tolosa E. When does Parkinson's disease begin?. Mov. Disord. 2009, 24:S656-S664.
29. Rada P., Avena N.M., Hoebel B.G. Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell. Neuroscience 2005, 134:737-744. 10.1016/j.neuroscience.2005.04.043.
30. Chong M.F., Fielding B.A., Frayn K.N. Metabolic interaction of dietary sugars and plasma lipids with a focus on mechanisms and de novo lipogenesis. Proc. Nutr. Soc. 2007, 66:52-59. 10.1017/S0029665107005290.
31. Chen H., Zhang S.M., Hernan M.A., Willett W.C., Ascherio A. Weight loss in Parkinson's disease. Ann. Neurol. 2003, 53:676-679. 10.1002/ana.10577.
32. Wang G.J., Volkow N.D., Fowler J.S. The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin. Ther. Targets 2002, 6:601-609.
33. Bastard J.P., Maachi M., Lagathu C., Kim M.J., Caron M., Vidal H., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 2006, 17:4-12.
34. Soltani Z., Rasheed K., Kapusta D.R., Reisin E. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?. Curr. Hypertens. Rep. 2013, 15:175-181. 10.1007/s11906-013-0344-5.
35. Weisskopf M.G., O'Reilly E., Chen H., Schwarzschild M.A., Ascherio A. Plasma urate and risk of Parkinson's disease. Am. J. Epidemiol. 2007, 166:561-567. doi: kwm127 [pii] 10.1093/aje/kwm127.